Home Kamada Ltd

Kamada Ltd

Profile managed by Bizz Id

Israel 1990

Description

Kamada Ltd is an Israeli plasma-derived biopharmaceutical company founded in 1990, based at 2 Holzman St, Science Park, Rehovot. Its website publishes six marketed proprietary products and two in development, across two families: alpha-1 antitrypsin augmentation therapy and hyperimmune immunoglobulins against cytomegalovirus, hepatitis B, rabies, varicella zoster and Rho(D). It also states that four further plasma-derived products are registered outside the United States, without naming them. It names one manufacturing plant, at MP Negev, Beit Kama, described as a sterile facility for plasma-derived therapies with Class 100 aseptic filling of 0.5 to 50 ml vials. Kamada Plasma, established in the United States in 2021, operates one donation centre in Beaumont, Texas. The company also distributes more than twenty third-party products in Israel, which are not part of this catalogue because it does not manufacture them.

Products

8 products

Alpha1-Proteinase Inhibitor (Human)

Augmentation and maintenance therapy for emphysema due to severe hereditary alpha1-antitrypsin deficiency. Brand Glassia. Ready-to-use intravenous solution for infusion.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Alpha1-Proteinase Inhibitor: see suppliers →

Cytomegalovirus Immune Globulin Intravenous (Human)

Prophylaxis of cytomegalovirus disease in solid organ transplantation. Brand Cytogam. Solution for infusion.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Cytomegalovirus Immunoglobulin: see suppliers →

Hepatitis B Immune Globulin Intravenous (Human)

Prevention of hepatitis B recurrence after liver transplant and post-exposure prophylaxis. Brand HepaGam B. Intravenous and intramuscular use.